CN101961455A - Traditional Chinese medicine for treating chronic colitis disease - Google Patents
Traditional Chinese medicine for treating chronic colitis disease Download PDFInfo
- Publication number
- CN101961455A CN101961455A CN2010102910997A CN201010291099A CN101961455A CN 101961455 A CN101961455 A CN 101961455A CN 2010102910997 A CN2010102910997 A CN 2010102910997A CN 201010291099 A CN201010291099 A CN 201010291099A CN 101961455 A CN101961455 A CN 101961455A
- Authority
- CN
- China
- Prior art keywords
- grams
- radix
- chinese medicine
- chronic colitis
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine for treating chronic colitis disease, which is prepared from the following raw materials: 30g of cochinchina momordica seed, 30g of sanchi powder, 30g of ginseng, 30g of Indian buead, 30g of largehead atractylodes rhizome, 30g of cuttlebone, 30g of cutch, 30g of garden burnet root, 30g of tuber bletillae, 30g of liquorice and 30g of seaweed. The dose accuracy of the traditional Chinese medicine is +/-10 percent of each raw material. The traditional Chinese medicine for treating the chronic colitis disease mainly treats diseases such as inflammatory edema, ulcer and haemorrhage of intestinal tract caused by various reasons, and has the advantages of obvious treatment effect, no recurrence after cure, safe and stable medicinal effect, and no toxic or side effect.
Description
Technical field
The present invention relates to a kind of medicine for the treatment of the colitis disease, especially a kind of Chinese medicine for the treatment of the chronic colitis disease.
Background technology
At present, chronic colitis is a kind of chronic, repeatability, multiple disease, with colon, sigmoid colon and rectum is site of pathological change, symptom mostly is that left lower quadrant is painful, diarrhoea, tenesmus, time just are stained with liquid, constipation down or are had loose bowels bad when replacing property generation, fashion, show effect repeatedly, the medicine general treatment time for the treatment of this disease is long, can cause toxic and side effects to liver, stomach, kidney, and self easily develops immunity to drugs sufferer, and therapeutic effect is unsatisfactory.
Summary of the invention
There are some unfavorable problems in order to solve chronic colitis treatment of diseases process, the invention provides a kind of Chinese medicine for the treatment of the chronic colitis disease, the Chinese medicine of this treatment chronic colitis disease cures mainly because of the various causes of disease and causes inflammatory edema, ulcer, the hemorrhage pathological changes of intestinal evident in efficacy, curing does not have repeatedly, the drug effect safety and stability, without any side effects.
Concrete proportioning of the present invention is: Semen Momordicae 30 gram, Radix Notoginseng powder 30 grams, Radix Ginseng 30 grams, Poria 30 grams, the Rhizoma Atractylodis Macrocephalae 30 grams, Endoconcha Sepiae 30 grams, catechu 30 grams, Radix Sanguisorbae 30 grams, the Pseudobulbus Bletillae (Rhizoma Bletillae) 30 grams, Radix Glycyrrhizae 30 grams, Sargassum 30 grams, the degree of accuracy of the dose of this Chinese medicine be each medicine ± 10%.
Pharmacology of the present invention is: Semen Momordicae: dispersing swelling and dissipating binds, the poison of dispelling; Endoconcha Sepiae: dehumidifying, antacid, stop blooding, hold back skin ulcer; Radix Notoginseng powder: hemostasis, dissipating blood stasis, analgesic therapy; Radix Ginseng: strongly invigorating primordial QI, invigorating the spleen to benefit the lung, promoting the production of body fluid to quench thirst, the Fructus Alpiniae Oxyphyllae of calming the nerves; Poria: diuresis, antibiotic antitumor; The Rhizoma Atractylodis Macrocephalae: invigorating the spleen and benefiting QI, dampness diuretic, hidroschesis; The Pseudobulbus Bletillae (Rhizoma Bletillae): astringing to arrest bleeding, detumescence and promoting granulation; Catechu: heat clearing away, promote the production of body fluid, stop blooding; Radix Sanguisorbae: antibiotic, antiinflammatory, hemostasis, promotion wound healing; Radix Glycyrrhizae: invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, expelling phlegm for arresting cough, relieving spasm to stop pain; Sargassum: clearing heat for detumescence.
Preparing process of the present invention: Semen Momordicae and the Rhizoma Atractylodis Macrocephalae are gone into pot respectively fry standby, Radix Sanguisorbae is gone into pot, mix stir-fry with Folium Pini, fried black getting final product until Radix Sanguisorbae, with the Semen Momordicae that fries, the Rhizoma Atractylodis Macrocephalae and fry black Radix Sanguisorbae and put into sieve with Radix Notoginseng powder, Radix Ginseng, Poria, Endoconcha Sepiae, catechu, the Pseudobulbus Bletillae (Rhizoma Bletillae), Radix Glycyrrhizae, dash with the clear water sieve, pull oven dry out after, grind to form fine powder with Sargassum again, machine is made pill and is got final product.
Administrated method of the present invention is: every day twice, each 5-6 gram.
The invention has the beneficial effects as follows: the Chinese medicine of this kind treatment chronic colitis disease cures mainly because of the various causes of disease cause inflammatory edema, ulcer, the hemorrhage pathological changes of intestinal evident in efficacy, and cure and do not have repeatedly, the drug effect safety and stability, without any side effects.
Specific embodiment
Through over 4 years, the clinical practice to 100 examples are treated the patient of chronic colitis diseases has obtained curative effect preferably, and total effective rate reaches 95%, and details are as follows for relevant clinical treatment situation:
1. patient profile: select projects such as medical history, the state of an illness, age, sex and original therapy method.
2. patient originates: with general hospital patient and professional OH patient.
3. case is gone into the group standard, and according to the clinical manifestation and the pathological characters branch of treatment chronic colitis disease, sex, age are not limit, stop using before the treatment other various medicines and therapeutic modality.
4. preparing process: Semen Momordicae and the Rhizoma Atractylodis Macrocephalae are gone into pot respectively fry standby, Radix Sanguisorbae is gone into pot, mix stir-fry with Folium Pini, fried black getting final product until Radix Sanguisorbae, black Radix Sanguisorbae and Radix Notoginseng powder, Radix Ginseng, Poria, Endoconcha Sepiae, catechu, the Pseudobulbus Bletillae (Rhizoma Bletillae), the Radix Glycyrrhizae of Semen Momordicae, the Rhizoma Atractylodis Macrocephalae and stir-fry that fries dashed with the clear water sieve, after pulling oven dry out, grind to form fine powder with Sargassum again, machine is made pill and is got final product.
5. administrated method: oral every day twice, each 5-6 gram.
6. efficacy evaluation
1. recovery from illness: transference cure, thoroughly recovery from illness.
2. remarkable: curing does not afterwards have recurrence more than 1 year.
3. effective: abdominal colic, nausea and vomiting, lassitude, deficiency of QI with disinclination to talk, symptoms such as limbs fatigue significantly reduce.
4. invalid: change not quite before and after the treatment, or once taking a turn for the better, after return to symptom before the treatment again.
7. efficacy analysis:
1. sex: according to going into the group standard, we treat chronic colitis disease patient 100 examples altogether, male's 60 examples (60%) wherein, women's 40 examples (40%).
2. the course of disease: 1～2 year is 30 examples, and 2 years～3 years is 40 examples, is 30 examples more than 3 years.
3. age group:, 27～30 years old 5 example, 31～40 years old 5 example, 41～50 years old 20 example, 51～60 years old 30 example, 40 examples more than 60 years old.
4. prepare the dose scheme for first kind: Semen Momordicae 33 restrains, Radix Notoginseng powder 33 restrains, Radix Ginseng 33 restrains, Poria 33 restrains, the Rhizoma Atractylodis Macrocephalae 33 restrains, Endoconcha Sepiae 33 restrains, catechu 33 restrains, Radix Sanguisorbae 33 restrains, the Pseudobulbus Bletillae (Rhizoma Bletillae) 33 restrains, Radix Glycyrrhizae 33 restrains, Sargassum 33 restrains.
The efficacy analysis of this scheme, administration time are 1～2 course of treatment.
| Patient's type | Recovery from illness | Significantly | Effectively | Invalid |
| Patients with mild 50 examples | 40 | 7 | 2 | 1 |
| Moderate patient's 35 examples | 30 | 2 | 2 | 1 |
| Severe patient 15 examples | 12 | 1 | 1 | 1 |
The scheme of second kind of preparation dose: Semen Momordicae 30 grams, Radix Notoginseng powder 30 grams, Radix Ginseng 30 grams, Poria 30 grams, the Rhizoma Atractylodis Macrocephalae 30 grams, Endoconcha Sepiae 30 grams, catechu 30 grams, Radix Sanguisorbae 30 grams, the Pseudobulbus Bletillae (Rhizoma Bletillae) 30 grams, Radix Glycyrrhizae 30 grams, Sargassum 30 grams.
The efficacy analysis of this scheme, administration time are 1～2 course of treatment.
| Patient's type | Recovery from illness | Significantly | Effectively | Invalid |
| Patients with mild 45 examples | 35 | 8 | 1 | 1 |
| Moderate patient's 40 examples | 35 | 3 | 1 | 1 |
| Severe patient 15 examples | 10 | 3 | 1 | 1 |
The scheme of the third preparation dose: Semen Momordicae 27 grams, Radix Notoginseng powder 27 grams, Radix Ginseng 27 grams, Poria 27 grams, the Rhizoma Atractylodis Macrocephalae 27 grams, Endoconcha Sepiae 27 grams, catechu 27 grams, Radix Sanguisorbae 27 grams, the Pseudobulbus Bletillae (Rhizoma Bletillae) 27 grams, Radix Glycyrrhizae 27 grams, Sargassum 27 grams.
The efficacy analysis of this scheme, administration time are 1～2 course of treatment.
| Patient's type | Recovery from illness | Significantly | Effectively | Invalid |
| Patients with mild 50 examples | 40 | 8 | 1 | 1 |
| Moderate patient's 40 examples | 35 | 3 | 1 | 1 |
| Severe patient 10 examples | 6 | 1 | 1 | 2 |
By Drug therapy chronic colitis disease of the present invention, received satisfied curative effect.The symptom of this disease is a lot, and this clinical experiment is divided into " slightly ", " moderate " and " seriously " several types according to clinical characters, and this clinical experiment is to carry out jointly at general hospital and special outpatient clinic.
Before this group case treatment, during most of patients was carried out, the treatment of doctor trained in Western medicine mode, but all do not obtain curative effect preferably, especially Western medicine is for oral administration, and side effect is bigger, and human body is developed immunity to drugs and causes very big toxic and side effects.In the process of the Chinese medicine medicine of taking treatment chronic enteritis disease of the present invention, must not take Western medicine and use injection, or other treats this sick medicine.
The Chinese medicine of this kind treatment chronic colitis disease cures mainly because of the various causes of disease cause inflammatory edema, ulcer, the hemorrhage pathological changes of intestinal evident in efficacy, and cure and do not have repeatedly, the drug effect safety and stability, without any side effects, cure rate reaches 95%.
Claims (2)
1. Chinese medicine for the treatment of the chronic colitis disease, it is characterized in that: concrete proportioning of the present invention is to choose Semen Momordicae 30 gram, Radix Notoginseng powder 30 grams, Radix Ginseng 30 grams, Poria 30 grams, the Rhizoma Atractylodis Macrocephalae 30 grams, Endoconcha Sepiae 30 grams, catechu 30 grams, Radix Sanguisorbae 30 grams, the Pseudobulbus Bletillae (Rhizoma Bletillae) 30 grams, Radix Glycyrrhizae 30 grams, Sargassum 30 grams, the degree of accuracy of the dose of this Chinese medicine be each medicine ± 10%.
2. a kind of Chinese medicine for the treatment of the chronic colitis disease according to claim 1, its preparing process feature is: Semen Momordicae and the Rhizoma Atractylodis Macrocephalae are gone into pot respectively fry standby, Radix Sanguisorbae is gone into pot, mix stir-fry with Folium Pini, fried black getting final product, the Semen Momordicae, the Rhizoma Atractylodis Macrocephalae and the black Radix Sanguisorbae of stir-fry that fry are put into sieve with Radix Notoginseng powder, Radix Ginseng, Poria, Endoconcha Sepiae, catechu, the Pseudobulbus Bletillae (Rhizoma Bletillae), Radix Glycyrrhizae until Radix Sanguisorbae, dash with the clear water sieve, after pulling oven dry out, grind to form fine powder with Sargassum again, machine is made pill and is got final product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010102910997A CN101961455A (en) | 2010-09-21 | 2010-09-21 | Traditional Chinese medicine for treating chronic colitis disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010102910997A CN101961455A (en) | 2010-09-21 | 2010-09-21 | Traditional Chinese medicine for treating chronic colitis disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101961455A true CN101961455A (en) | 2011-02-02 |
Family
ID=43514629
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010102910997A Pending CN101961455A (en) | 2010-09-21 | 2010-09-21 | Traditional Chinese medicine for treating chronic colitis disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101961455A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102940779A (en) * | 2012-11-27 | 2013-02-27 | 石家庄平安医院有限公司 | Medicine composition for treating chronic ulcerative colitis and preparation process of medicine composition |
| CN103142726A (en) * | 2013-02-21 | 2013-06-12 | 上海浦东高星生物技术研究所 | Ulcer hemorrhage stopping powder |
| CN107753744A (en) * | 2016-08-16 | 2018-03-06 | 陈琼芳 | A kind of outer medicine for controlling ulcerative colitis |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1214248A (en) * | 1997-10-14 | 1999-04-21 | 高学剑 | Chinese medicine for digestive system diseases |
-
2010
- 2010-09-21 CN CN2010102910997A patent/CN101961455A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1214248A (en) * | 1997-10-14 | 1999-04-21 | 高学剑 | Chinese medicine for digestive system diseases |
Non-Patent Citations (1)
| Title |
|---|
| 《陕西中医》 19961231 潘炳森等 中医药治疗慢性溃疡性结肠炎近况 , 第01期 2 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102940779A (en) * | 2012-11-27 | 2013-02-27 | 石家庄平安医院有限公司 | Medicine composition for treating chronic ulcerative colitis and preparation process of medicine composition |
| CN102940779B (en) * | 2012-11-27 | 2014-01-08 | 石家庄平安医院有限公司 | Medicine composition for treating chronic ulcerative colitis and preparation process of medicine composition |
| CN103142726A (en) * | 2013-02-21 | 2013-06-12 | 上海浦东高星生物技术研究所 | Ulcer hemorrhage stopping powder |
| CN107753744A (en) * | 2016-08-16 | 2018-03-06 | 陈琼芳 | A kind of outer medicine for controlling ulcerative colitis |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104523865A (en) | Medicine for treating breast diseases | |
| CN101961449B (en) | Traditional Chinese medicine for treating tinea corporis | |
| CN102188685B (en) | Externally-applied traditional Chinese medicine powder for treating diarrhea type irritable bowel syndrome and preparation method thereof | |
| CN102078462A (en) | Asthma relieving medicament | |
| CN101983644A (en) | Medicament for treating sequelae of apoplexy | |
| CN102145101A (en) | Novel traditional Chinese medicine for treating rheumatic lumbocrural pains | |
| CN101961455A (en) | Traditional Chinese medicine for treating chronic colitis disease | |
| CN102078472A (en) | Medicament for treating verruca wart | |
| CN101983672A (en) | Medicament for treating cramp | |
| CN101259214B (en) | Medicine for treating hyperplasia of mammary glands | |
| CN103239677B (en) | Anorectal medicine used for treating ascites and preparation method of anorectal medicine preparation | |
| CN101979035A (en) | Medicament for treating gynecological abnormal leucorrhea | |
| CN101983682A (en) | Medicament for treating female climacteric metancholia | |
| CN101983650A (en) | Medicament for treating dermatitis aestivale | |
| CN102078432A (en) | Medicament for treating skin itch | |
| CN104258275A (en) | Traditional Chinese medicinal composition for treating benign ovarian tumor with syndrome of internal blood stasis | |
| CN103768290A (en) | Traditional Chinese medicine composition for treating synovitis and preparation method thereof | |
| CN101953943A (en) | Traditional Chinese medicine for treating chronic aplastic anemia | |
| CN101983712A (en) | Novel medicament for treating coronary heart disease | |
| CN101979072A (en) | Chinese medicament for treating chronic liver disease | |
| CN101167915B (en) | Traditional Chinese medicine for treating chronic superficial gastritis and its preparation method | |
| CN105687659A (en) | Medicine patch for treating cesarean-postoperative abdominal incision sclerosis | |
| CN105726849B (en) | It is a kind of for treating the Chinese medicine of diabetes Depression | |
| CN102078387A (en) | Traditional Chinese medicine for treating fibroid and ovarian cyst | |
| CN104645224A (en) | Traditional Chinese medicine preparation for treating costal chondritis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| AD01 | Patent right deemed abandoned |
Effective date of abandoning: 20110202 |
|
| C20 | Patent right or utility model deemed to be abandoned or is abandoned |